FDA’s Landmark Shift Away from Animal Testing
On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a strategic roadmap to phase out the requirement for animal testing in the development of monoclonal antibodies and other therapeutic drugs. This represents a pivotal transformation in regulatory… Read More »FDA’s Landmark Shift Away from Animal Testing